Table 4. Depression, anxiety, stress and HRQoL among sarcoma survivors.
| EORTC QoL sub-scales |
Mean rank | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| With depression | Without depression | p-valuea | With anxiety | Without anxiety | p-valuea | With stress | Without stress | p-valuea | |
| Financial difficulty | 57.72 | 49.13 | 0.232 | 63.58 | 47.23 | 0.013* | 72.93 | 48.81 | 0.020* |
| Global health status/QoL | 44.91 | 51.57 | 0.390 | 43.40 | 52.28 | 0.211 | 55.50 | 50.12 | 0.629 |
| Functioning sub-scales | |||||||||
| Physical functioning | 53.78 | 49.88 | 0.614 | 43.03 | 52.37 | 0.189 | 47.36 | 50.74 | 0.762 |
| Role functioning | 51.03 | 50.40 | 0.933 | 47.93 | 51.14 | 0.640 | 57.30 | 49.97 | 0.486 |
| Emotional functioning | 28.56 | 54.68 | 0.001* | 30.23 | 55.57 | <0.001* | 22.71 | 52.59 | 0.008* |
| Cognitive functioning | 38.72 | 52.17 | 0.056 | 31.85 | 54.59 | <0.001* | 23.00 | 52.05 | 0.004* |
| Social functioning | 44.69 | 51.61 | 0.361 | 41.68 | 52.71 | 0.112 | 36.29 | 51.57 | 0.160 |
| Symptoms sub-scales | |||||||||
| Dyspnoea | 43.50 | 51.83 | 0.080 | 48.50 | 51.00 | 0.566 | 50.64 | 50.49 | 0.982 |
| Pain | 55.66 | 49.52 | 0.423 | 64.78 | 46.93 | 0.011* | 71.07 | 48.95 | 0.044* |
| Insomnia | 59.47 | 48.31 | 0.079 | 68.63 | 45.58 | <0.001* | 72.42 | 48.55 | 0.013* |
| Fatigue | 62.50 | 48.21 | 0.067 | 75.53 | 44.24 | <0.001* | 82.29 | 48.11 | 0.002* |
| Anorexia | 52.56 | 50.11 | 0.693 | 61.98 | 47.63 | 0.012* | 64.93 | 49.41 | 0.083 |
| Nausea/Vomiting | 50.47 | 50.51 | 0.995 | 68.10 | 46.10 | <0.001* | 78.29 | 48.41 | 0.001* |
| Constipation | 49.41 | 50.71 | 0.823 | 58.15 | 48.59 | 0.073 | 54.86 | 50.17 | 0.575 |
| Diarrhoea | 46.13 | 51.33 | 0.362 | 51.93 | 50.14 | 0.734 | 47.86 | 50.70 | 0.729 |
U = Mann–Whitney U test; p = significance level
EORTC QoL= European Organisation for Research and Treatment of Cancer Quality of Life
Statistically significant where p < 0.05 and two tailed